1. Imaging in Bladder Cancer: Can We Do Better?
2. New Optical Improvements in Bladder Cancer Diagnosis: Seeing Better for a Better Management?
3. Enhancing the Quality of Transurethral Resection: The Importance of a Complete TURB and the En-Bloc Resection
4. Active Surveillance for Low-Risk Non-Muscle Invasive Bladder Cancer
5. How Good Are We at Predicting Outcomes in Non-Muscle Invasive Bladder Cancer?
6. Adjuvant Treatment: Old and New Immunotherapy in Non-Muscle-Invasive Bladder Cancer
7. The Role of New Experimental Conservative Therapies for High Risk Non-Muscle Invasive Bladder Cancer: Could We Trust Them?
8. Is There Still a Role for Radical Cystectomy?
9. Minimally Invasive Radical Cystectomy and Its Role and Future in Treatment of Bladder Cancer Patients. Myth or Reality?
10. Neoadjuvant vs. Adjuvant Chemotherapy: Which Is Right?
11. Radiotherapy for the Treatment of Muscle-Invasive Bladder Cancer
12. Immunotherapy and New Combinations in Muscle-Invasive Bladder Cancer
13. The Role of Urologist
14. A View of the Future: The Role of Pathologists
15. The Role of Medical Oncologist
16. The Future of Radiotherapy in Bladder Cancer
This book aims to bring together the current research and discussions surrounding bladder cancer management. New technologies and therapeutic agents have become increasingly effective at treating urothelial bladder cancer and have created a range of opportunities to change the ways in which the disease is treated. Chapters cover the changes in adjuvant treatment, confocal laser endomicroscopy, and the roles of oncologists, pathologists, and radiotherapists in managing bladder cancer.
Treating Urothelial Bladder Cancer is particularly relevant to urologists, oncologists, and radiotherapists, but is also applicable to practitioners, geriatricians, and public health managers due to its multidisciplinary approach to bladder cancer management.
• Focuses on the newest aspects of bladder cancer management
• Features clinical cases in each section
• Covers many controversial aspects of the field
• Paolo Gontero is Associate Professor of Urology at the University of Torino, Italy and currently Chairmen of the Division of Urology, San Giovanni Battista Hospital, Torino, Italy. His main clinical interests are Oncology Urology Surgery, Laparoscopic and Robotic kidney and prostate oncological surgery and Reconstructive Urology. He has authored and co-authored more than 200 publications on international journals.
• Francesco Soria is Consultant Urologist at University of Vienna (Urologist, MD, FEBU).